gv...MACE vs. QoL vs. Lipitor-Crestor or 208.....so thinking forward, if 208 proves to possess a 27.5% RRR MACE vs. others, in real life would that be meaningful to your doctor or is it a whole range of QoL factors that come into play, knowing i suspect that in real life having a re-MACE is likely a much smaller likely outcome than what may occur in this trial (as IMO doctors monitor high risk patients and intervene early and as needed)..so what all comes into play (patient factors) into using Lipitor Crestor or 208???